VentureLink LP

VentureLink LP was a principal investment firm based in Toronto, Ontario, specializing in equity holdings and mezzanine financing. The firm focused on investing in early-stage venture companies and also engaged in debt-related securities, including convertible notes, warrants, and debentures, which allowed participation in business growth. VentureLink LP targeted investments in various sectors, including financial, manufacturing, service, alternative energy, and technology industries, primarily within Canada. However, the firm is no longer in business.

Jim Whitaker

Managing Partner

27 past transactions

eSentire

Series C in 2014
eSentire is a leading provider of managed detection and response cybersecurity services, dedicated to protecting the critical data and applications of over 1,500 organizations across more than 80 countries and 35 industries. Founded in 2001, the company focuses on hunting, investigating, and neutralizing cyber threats before they disrupt business operations. eSentire combines advanced machine learning technology with round-the-clock threat hunting and experienced security operations leadership to reduce business risks and enhance security measures. The company offers a range of services, including managed risk programs, digital forensics, incident response, and tailored support from dedicated Cyber Risk Advisors and expert threat hunters. By leveraging industry-leading threat intelligence research, eSentire ensures that its clients can secure both their internal and cloud environments effectively.

eSentire

Series B in 2013
eSentire is a leading provider of managed detection and response cybersecurity services, dedicated to protecting the critical data and applications of over 1,500 organizations across more than 80 countries and 35 industries. Founded in 2001, the company focuses on hunting, investigating, and neutralizing cyber threats before they disrupt business operations. eSentire combines advanced machine learning technology with round-the-clock threat hunting and experienced security operations leadership to reduce business risks and enhance security measures. The company offers a range of services, including managed risk programs, digital forensics, incident response, and tailored support from dedicated Cyber Risk Advisors and expert threat hunters. By leveraging industry-leading threat intelligence research, eSentire ensures that its clients can secure both their internal and cloud environments effectively.

Sidense

Series C in 2013
Sidense is a prominent developer of silicon-proven embedded non-volatile memory (NVM) intellectual property (IP). The company specializes in one-time programmable (OTP) memory and logic NVM, which are designed to enhance a variety of electronic products. Sidense's IP cores facilitate code storage and processor configuration, allowing semiconductor and systems companies to differentiate their products while optimizing design efficiency. By integrating these IP cores into system-on-chip (SoC) designs, clients can achieve a smaller footprint and improved performance in their electronic offerings.

Sidense

Series C in 2011
Sidense is a prominent developer of silicon-proven embedded non-volatile memory (NVM) intellectual property (IP). The company specializes in one-time programmable (OTP) memory and logic NVM, which are designed to enhance a variety of electronic products. Sidense's IP cores facilitate code storage and processor configuration, allowing semiconductor and systems companies to differentiate their products while optimizing design efficiency. By integrating these IP cores into system-on-chip (SoC) designs, clients can achieve a smaller footprint and improved performance in their electronic offerings.

Covarity

Venture Round in 2010
Covarity, Inc. specializes in developing online solutions for post-origination commercial loan monitoring and analysis, aimed at enhancing the performance and health of financial institutions' loan portfolios. The company automates the collection and analysis of borrower financial data, allowing lenders to manage credit risk on an individual loan basis. Covarity's services include borrower tracking, financial document parsing, and portfolio reporting, which provide the insight and control necessary for lenders to grow their portfolios while minimizing risk and improving client service. Its modular software solutions are tailored to meet the specific needs of banks, credit unions, and other lenders in Canada, helping them manage collateral reviews and financial assessments efficiently. Founded in 1999 and based in Kitchener, Canada, Covarity serves notable clients such as RBC Financial, BMO Financial, and Laurentian Bank, enabling them to enhance competitiveness and reduce operational costs.

Sidense

Series B in 2010
Sidense is a prominent developer of silicon-proven embedded non-volatile memory (NVM) intellectual property (IP). The company specializes in one-time programmable (OTP) memory and logic NVM, which are designed to enhance a variety of electronic products. Sidense's IP cores facilitate code storage and processor configuration, allowing semiconductor and systems companies to differentiate their products while optimizing design efficiency. By integrating these IP cores into system-on-chip (SoC) designs, clients can achieve a smaller footprint and improved performance in their electronic offerings.

Peraso Technologies

Series A in 2009
Peraso Technologies Inc. is a fabless semiconductor company based in Toronto, Canada, specializing in the development of multi-gigabit millimeter wave single-chip transceivers. The company focuses on creating array antenna solutions and 60 GHz wireless chipsets that comply with the IEEE 802.11ad specification. Its product lineup includes chipsets such as the W120, X710, and X610, which are designed for use in mobile consumer electronics like smartphones and tablets. Peraso's technology supports a variety of applications, including mobile rapid sync-n-go, wireless networking, in-room HD video streaming, and vehicle-to-vehicle communication. Founded in 2008, the company also offers custom solutions to meet specific customer needs in various sectors.

Covarity

Venture Round in 2009
Covarity, Inc. specializes in developing online solutions for post-origination commercial loan monitoring and analysis, aimed at enhancing the performance and health of financial institutions' loan portfolios. The company automates the collection and analysis of borrower financial data, allowing lenders to manage credit risk on an individual loan basis. Covarity's services include borrower tracking, financial document parsing, and portfolio reporting, which provide the insight and control necessary for lenders to grow their portfolios while minimizing risk and improving client service. Its modular software solutions are tailored to meet the specific needs of banks, credit unions, and other lenders in Canada, helping them manage collateral reviews and financial assessments efficiently. Founded in 1999 and based in Kitchener, Canada, Covarity serves notable clients such as RBC Financial, BMO Financial, and Laurentian Bank, enabling them to enhance competitiveness and reduce operational costs.

SCI Marketview

Venture Round in 2008
High quality consumer information automotive dealers can use, not data they have to decipher. Our straightforward delivery of real, actionable and easy to understand lead information, has made significant contributions to the overall sales success of over 4,000 automotive dealers, throughout North America. Specialties Leads Management & Delivery, Leads Consolidation and Standardization, Campaign Marketing, Lead Management Software, CRM, Automotive, Lead Management

Cytochroma

Series C in 2008
Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.

Sidense

Series A in 2008
Sidense is a prominent developer of silicon-proven embedded non-volatile memory (NVM) intellectual property (IP). The company specializes in one-time programmable (OTP) memory and logic NVM, which are designed to enhance a variety of electronic products. Sidense's IP cores facilitate code storage and processor configuration, allowing semiconductor and systems companies to differentiate their products while optimizing design efficiency. By integrating these IP cores into system-on-chip (SoC) designs, clients can achieve a smaller footprint and improved performance in their electronic offerings.

Destinator Technologies

Venture Round in 2007
Destinator Technologies, Inc. provides navigation software for personal navigation devices and smart phones. It also offers software development kits for developing individual and company specific navigation solutions. The company serves consumer brands and mobile device manufacturers. The company was founded as Homeland Security Technology Corporation in 2003 and changed its name to Destinator Technologies, Inc. in 2005. The company is headquartered in Richmond Hill, Canada with additional offices in the United States, Canada, Germany, Israel, Taiwan, and China. As of July 9, 2008, Destinator Technologies Inc. operates as a subsidiary of Intrinsyc Software International Inc.

Covarity

Venture Round in 2007
Covarity, Inc. specializes in developing online solutions for post-origination commercial loan monitoring and analysis, aimed at enhancing the performance and health of financial institutions' loan portfolios. The company automates the collection and analysis of borrower financial data, allowing lenders to manage credit risk on an individual loan basis. Covarity's services include borrower tracking, financial document parsing, and portfolio reporting, which provide the insight and control necessary for lenders to grow their portfolios while minimizing risk and improving client service. Its modular software solutions are tailored to meet the specific needs of banks, credit unions, and other lenders in Canada, helping them manage collateral reviews and financial assessments efficiently. Founded in 1999 and based in Kitchener, Canada, Covarity serves notable clients such as RBC Financial, BMO Financial, and Laurentian Bank, enabling them to enhance competitiveness and reduce operational costs.

EnerWorks

Venture Round in 2006
EnerWorks is a North American solar thermal technology provider With proven, patented technology and certified systems, EnerWorks offers high quality, reliable, and cost-effective renewable energy solutions to the North American and Caribbean markets. EnerWorks develops and manufactures proprietary renewable energy appliances for residential, commercial, and industrial markets. EnerWorks is at the forefront of integrated solar thermal solutions, working with local partners to design, install, commission, and maintain solar thermal heating and cooling systems.

Performance Plants

Venture Round in 2006
Performance Plants Inc. (PPI) is a privately owned, internationally recognized, mature agriculture biotechnology developer with a series of powerful, validated ‘game-changing’ technologies that are readily applied to major staple crops for significant improvement of their productivity. The company has a solid R&D platform, a robust pipeline of products, and a successful commercialization strategy that has secured licensing or co-development agreements with many major multinational seed companies such as Bayer Cropscience, RiceTec, DBN, Biocentury Transgene and Mahyco. The company has recently opened up the Chinese and Indian market by establishing multiple licensing and commercial product development agreements with leading Chinese and Indian seed and agricultural biotechnology companies. Performance Plants is involved in gene discovery, trait development & commercialization of technologies for seeds to protect and enhance yields in all major crops globally. PPI’s technology will allow farmers in many countries to increase yields and reduce the need for irrigation, particularly in drought and heat stressed areas. It also reduces the need for other costly and potentially harmful chemicals while helping to feed a growing population and reduces emissions and water usage. Their technology has shown to increase the yield of biomass for non-food biofuel crops. PPI does not introduce any foreign genes into its products; rather it regulates the plant's own genes to increase or decrease expression of the genes responsible for key traits. In August 2013, PPI signed their 3rd commercial license agreement with Bayer CropScience for the use of PPI’s Heat and Drought Tolerance Technology in wheat. This agreement is significant as wheat is very susceptible to heat above 26 degrees Celsius. Bayer CropScience is a world leader in wheat seed sales and in development of next generation high-yielding wheat crops using biotechnologies.

Covarity

Series B in 2006
Covarity, Inc. specializes in developing online solutions for post-origination commercial loan monitoring and analysis, aimed at enhancing the performance and health of financial institutions' loan portfolios. The company automates the collection and analysis of borrower financial data, allowing lenders to manage credit risk on an individual loan basis. Covarity's services include borrower tracking, financial document parsing, and portfolio reporting, which provide the insight and control necessary for lenders to grow their portfolios while minimizing risk and improving client service. Its modular software solutions are tailored to meet the specific needs of banks, credit unions, and other lenders in Canada, helping them manage collateral reviews and financial assessments efficiently. Founded in 1999 and based in Kitchener, Canada, Covarity serves notable clients such as RBC Financial, BMO Financial, and Laurentian Bank, enabling them to enhance competitiveness and reduce operational costs.

Spotwave Wireless

Venture Round in 2006
Spotwave Wireless specializes in providing carrier-approved indoor wireless coverage solutions, ensuring reliable and consistent connectivity for users in environments where wireless devices are most utilized. The company offers a range of products designed for various networks, including GSM and CDMA, catering to the needs of wireless carriers, enterprises, and consumers. By delivering effective and affordable coverage solutions, Spotwave enables its customers to maintain seamless wireless communication indoors, enhancing both operational efficiency and user experience.

Performance Plants

Venture Round in 2005
Performance Plants Inc. (PPI) is a privately owned, internationally recognized, mature agriculture biotechnology developer with a series of powerful, validated ‘game-changing’ technologies that are readily applied to major staple crops for significant improvement of their productivity. The company has a solid R&D platform, a robust pipeline of products, and a successful commercialization strategy that has secured licensing or co-development agreements with many major multinational seed companies such as Bayer Cropscience, RiceTec, DBN, Biocentury Transgene and Mahyco. The company has recently opened up the Chinese and Indian market by establishing multiple licensing and commercial product development agreements with leading Chinese and Indian seed and agricultural biotechnology companies. Performance Plants is involved in gene discovery, trait development & commercialization of technologies for seeds to protect and enhance yields in all major crops globally. PPI’s technology will allow farmers in many countries to increase yields and reduce the need for irrigation, particularly in drought and heat stressed areas. It also reduces the need for other costly and potentially harmful chemicals while helping to feed a growing population and reduces emissions and water usage. Their technology has shown to increase the yield of biomass for non-food biofuel crops. PPI does not introduce any foreign genes into its products; rather it regulates the plant's own genes to increase or decrease expression of the genes responsible for key traits. In August 2013, PPI signed their 3rd commercial license agreement with Bayer CropScience for the use of PPI’s Heat and Drought Tolerance Technology in wheat. This agreement is significant as wheat is very susceptible to heat above 26 degrees Celsius. Bayer CropScience is a world leader in wheat seed sales and in development of next generation high-yielding wheat crops using biotechnologies.

Covarity

Series A in 2003
Covarity, Inc. specializes in developing online solutions for post-origination commercial loan monitoring and analysis, aimed at enhancing the performance and health of financial institutions' loan portfolios. The company automates the collection and analysis of borrower financial data, allowing lenders to manage credit risk on an individual loan basis. Covarity's services include borrower tracking, financial document parsing, and portfolio reporting, which provide the insight and control necessary for lenders to grow their portfolios while minimizing risk and improving client service. Its modular software solutions are tailored to meet the specific needs of banks, credit unions, and other lenders in Canada, helping them manage collateral reviews and financial assessments efficiently. Founded in 1999 and based in Kitchener, Canada, Covarity serves notable clients such as RBC Financial, BMO Financial, and Laurentian Bank, enabling them to enhance competitiveness and reduce operational costs.

Encelium

Series A in 2003
Encelium Technologies is a company focused on developing advanced integrated lighting control systems for commercial buildings. Its offerings include light management services that collect data from various lighting component suppliers to optimize lighting usage according to changing needs. By implementing these systems, commercial buildings can achieve significant energy savings and enhance their return on investment. Encelium's technology aims to create efficient and adaptable lighting solutions that meet the demands of modern commercial environments.

Cytochroma

Series B in 2001
Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.

Cytochroma

Series B in 2001
Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.